Evidence map›Paper›PMID 34443556›Full record

ArticleMolecules (Basel, Switzerland)2021

Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD.

Thamer A Bouback, Sushil Pokhrel, Abdulaziz Albeshri, Amal Mohammed Aljohani, Abdus Samad, Rahat Alam, Md Saddam Hossen, Khalid Al-Ghamdi, Md Enamul Kabir Talukder, Foysal Ahammad and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Chemoinformatics analysis ofFrontiers in chemistry · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Thamer A BoubackDepartment of Biological Science, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
Sushil PokhrelDepartment of Biomedical Engineering, State University of New York (SUNY), Binghamton, NY 13902, USA.
Abdulaziz AlbeshriDepartment of Biological Science, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-0718-2439
Amal Mohammed AljohaniDepartment of Biological Science, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
Abdus SamadDepartment of Genetic Engineering and Biotechnology, Faculty of Biological Science and Technology, Jashore University of Science and Technology, Jashore 7408, Bangladesh.ORCID 0000-0003-4336-5600
Rahat AlamDepartment of Genetic Engineering and Biotechnology, Faculty of Biological Science and Technology, Jashore University of Science and Technology, Jashore 7408, Bangladesh.ORCID 0000-0001-9415-9386
Md Saddam HossenDepartment of Genetic Engineering and Biotechnology, Faculty of Biological Science and Technology, Jashore University of Science and Technology, Jashore 7408, Bangladesh.ORCID 0000-0002-8258-3291
Khalid Al-GhamdiDepartment of Biological Science, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
Md Enamul Kabir TalukderDepartment of Genetic Engineering and Biotechnology, Faculty of Biological Science and Technology, Jashore University of Science and Technology, Jashore 7408, Bangladesh.
Foysal AhammadDepartment of Biological Science, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0001-7313-4729
Ishtiaq QadriDepartment of Biological Science, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
Jesus Simal-GandaraNutrition and Bromatology Group, Department of Analytical Chemistry and Food Science, Faculty of Food Science and Technology, University of Vigo-Ourense Campus, E-32004 Ourense, Spain.ORCID 0000-0001-9215-9737
Binghamton University · USUniversidade de Vigo · ESZhejiang Sci-Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly infectious zoonotic virus first reported into the human population in September 2012 on the Arabian Peninsula. The virus causes severe and often lethal respiratory illness in humans with an unusually high fatality rate. The N-terminal domain (NTD) of receptor-binding S1 subunit of coronavirus spike (S) proteins can recognize a variety of host protein and mediates entry into human host cells. Blocking the entry by targeting the S1-NTD of the virus can facilitate the development of effective antiviral drug candidates against the pathogen. Therefore, the study has been designed to identify effective antiviral drug candidates against the MERS-CoV by targeting S1-NTD. Initially, a structure-based pharmacophore model (SBPM) to the active site (AS) cavity of the S1-NTD has been generated, followed by pharmacophore-based virtual screening of 11,295 natural compounds. Hits generated through the pharmacophore-based virtual screening have re-ranked by molecular docking and further evaluated through the ADMET properties. The compounds with the best ADME and toxicity properties have been retrieved, and a quantum mechanical (QM) based density-functional theory (DFT) has been performed to optimize the geometry of the selected compounds. Three optimized natural compounds, namely Taiwanhomoflavone B (Amb23604132), 2,3-Dihydrohinokiflavone (Amb23604659), and Sophoricoside (Amb1153724), have exhibited substantial docking energy >-9.00 kcal/mol, where analysis of frontier molecular orbital (FMO) theory found the low chemical reactivity correspondence to the bioactivity of the compounds. Molecular dynamics (MD) simulation confirmed the stability of the selected natural compound to the binding site of the protein. Additionally, molecular mechanics generalized born surface area (MM/GBSA) predicted the good value of binding free energies (ΔG bind) of the compounds to the desired protein. Convincingly, all the results support the potentiality of the selected compounds as natural antiviral candidates against the MERS-CoV S1-NTD.

Indexed as

Antiviral AgentsMiddle East Respiratory Syndrome CoronavirusMolecular Docking SimulationMolecular Dynamics SimulationSpike Glycoprotein, CoronavirusBiological ProductsDrug Evaluation, PreclinicalHumansPharmacophoreProtein BindingQuantum TheoryAntiviral AgentsBiological ProductsSpike Glycoprotein, CoronavirusADMEDFTFMOHOMOLUMOMERS-CoVMM/GBSAmolecular dockingMolecular Dynamics Simulationpharmacophore modelingquantum mechanical calculationS1-NTD

Identifiers

PMID34443556
PMCPMC8401589
OpenAlexW3195786484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.